Inventor
PEDERSEN LYKKE
DK24 patents
⚠️ This page may combine multiple inventors who share the name “PEDERSEN LYKKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
19 patentsUS11852627B2Dec 26, 2023
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US11320421B2May 3, 2022
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US10953034B2Mar 23, 2021
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
HOFFMANN LA ROCHE5 citations81
US12259380B2Mar 25, 2025
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE2 citations73
US11534452B2Dec 27, 2022
Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection
HOFFMANN LA ROCHE2 citations71
US11484546B2Nov 1, 2022
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
HOFFMANN LA ROCHE3 citations70
US11466081B2Oct 11, 2022
Oligonucleotides for reduction of PD-L1 expression
HOFFMANN LA ROCHE2 citations70
US10829555B2Nov 10, 2020
Oligonucleotides for reduction of PD-L1 expression
HOFFMANN LA ROCHE3 citations70
US10745480B2Aug 18, 2020
Oligonucleotides for reduction of PD-L1 expression
HOFFMANN LA ROCHE3 citations70
US12566172B2Mar 3, 2026
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE0 citations61
US12552862B2Feb 17, 2026
Oligonucleotides for reduction of PD-L1 expression
HOFFMANN LA ROCHE0 citations59
US12303525B2May 20, 2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
HOFFMANN LA ROCHE1 citations58
US11286485B2Mar 29, 2022
Oligonucleotides for modulating ATXN2 expression
HOFFMANN LA ROCHE0 citations56
US11066669B2Jul 20, 2021
Oligonucleotides for modulating ATXN2 expression
HOFFMANN LA ROCHE0 citations55
US11898145B2Feb 13, 2024
Enhanced oligonucleotides for inhibiting RTEL1 expression
HOFFMANN LA ROCHE0 citations53
US12116576B2Oct 15, 2024
Oligonucleotides for modulating SCN9A expression
HOFFMANN LA ROCHE0 citations51
US11542501B2Jan 3, 2023
Antisense oligonucleotides targeting ATXN3
HOFFMANN LA ROCHE1 citations51
US12497621B2Dec 16, 2025
Oligonucleotides for modulating RTEL1 expression
HOFFMANN LA ROCHE0 citations48
US10519450B2Dec 31, 2019
Antisense oligonucleotides for modulating HTRA1 expression
HOFFMANN LA ROCHE0 citations44
ROCHE INNOVATION CT COPENHAGEN AS
3 patentsUS10494633B2Dec 3, 2019
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS8 citations91
US10739332B2Aug 11, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS6 citations82
US10718753B2Jul 21, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS5 citations82